Free Trial
→ What President Trump’s Executive Order 14154 means for your money (From Stansberry Research) (Ad) Buy LPTX Stock  Free LPTX Stock Alerts

Leap Therapeutics (LPTX) Institutional Ownership

Leap Therapeutics logo
$0.42 +0.03 (+7.95%)
As of 04/30/2025 04:00 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for Leap Therapeutics (NASDAQ:LPTX)

Current
Institutional Ownership
Percentage
30.46%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$26.56M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$974.87K
Get LPTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Leap Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LPTX Institutional Buying and Selling by Quarter

Leap Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Point72 Asset Management L.P.1,400,000$4.03M0.0%N/A3.653%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 105,108$302K0.0%-36.3%0.274%
2/17/2025J. Goldman & Co LP67,500$194K0.0%N/A0.176%
2/17/2025683 Capital Management LLC1,350,000$3.88M0.2%-2.2%3.523%
2/14/2025Jane Street Group LLC37,098$107K0.0%N/A0.097%
2/14/2025Dauntless Investment Group LLC50,000$144K0.2%N/A0.130%
2/14/2025Gilead Sciences Inc.5,319,148$15.29M1.0%N/A13.881%
2/13/2025Marshall Wace LLP185,690$535K0.0%+251.1%0.485%
2/13/2025NewEdge Advisors LLC50,045$144K0.0%+1,668,066.7%0.131%
2/13/2025ADAR1 Capital Management LLC106,000$305K0.1%N/A0.277%
2/12/2025Knott David M Jr23,626$68K0.0%-63.8%0.062%
2/12/2025BIT Capital GmbH282,008$811K0.1%+248.2%0.736%
2/11/2025LPL Financial LLC75,800$218K0.0%N/A0.198%
2/11/2025Simplify Asset Management Inc.946,046$2.72M0.1%-10.5%2.469%
2/10/2025Monaco Asset Management SAM205,874$592K0.1%N/A0.537%
2/7/2025HighTower Advisors LLC52,500$151K0.0%+105.9%0.137%
2/7/2025 Prosperity Wealth Management Inc.22,000$63K0.0%N/A0.057%
1/17/2025 Key Client Fiduciary Advisors LLC361,253$1.04M0.5%+12.2%0.943%
1/15/2025HB Wealth Management LLC51,500$150K0.0%+103.2%0.134%
12/13/2024Exome Asset Management LLC102,631$264K0.2%N/A0.268%
11/16/2024Geode Capital Management LLC329,291$847K0.0%+18.0%1.286%
11/15/2024HighTower Advisors LLC25,500$65K0.0%N/A0.100%
11/14/2024Acuta Capital Partners LLC120,500$310K0.3%-38.2%0.471%
11/12/2024Valence8 US LP18,511$48K0.0%N/A0.072%
11/6/2024Simplify Asset Management Inc.1,056,895$2.72M0.1%+67.4%4.128%
10/18/2024 Key Client Fiduciary Advisors LLC321,923$827K0.4%+13.0%1.258%
8/14/2024Marshall Wace LLP79,758$156K0.0%+268.2%0.312%
8/13/2024Simplify Asset Management Inc.631,269$1.24M0.1%+67.9%2.466%
8/9/2024Renaissance Technologies LLC97,670$191K0.0%-14.7%0.382%
8/6/2024Acadian Asset Management LLC256,655$501K0.0%-9.1%1.003%
7/16/2024 Key Client Fiduciary Advisors LLC284,856$558K0.3%+22.2%1.113%
5/10/2024Acadian Asset Management LLC282,413$750K0.0%+349.3%1.103%
5/10/2024Vanguard Group Inc.867,708$2.31M0.0%+111.7%3.389%
4/15/2024 Key Client Fiduciary Advisors LLC233,018$620K0.3%+8.6%0.910%
1/9/2024 Key Client Fiduciary Advisors LLC214,610$890K0.5%-5.6%0.839%
11/15/2023 Key Client Fiduciary Advisors LLC227,273$314K0.2%+43.3%0.889%
11/15/2023Acuta Capital Partners LLC354,166$489K0.3%N/A1.385%
11/14/2023683 Capital Management LLC490,000$676K0.1%+60.7%1.916%
10/27/2023TD Asset Management Inc46,994$65K0.0%+100.0%0.184%
8/24/2023Perceptive Advisors LLC586,733$1.84M0.1%-91.3%4.914%
The collapse has already started (Ad)

The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim Plaehn reveals how the 2025 trade war is quietly eroding dividend income — and which U.S.-focused stocks are still raising payouts.

Watch the 2025 Trade War dividend protection briefing now
8/14/2023Samsara BioCapital LLC602,203$1.89M0.3%-28.8%5.044%
8/14/2023683 Capital Management LLC304,999$955K0.1%-89.1%2.554%
8/14/2023Cormorant Asset Management LP1,073,046$3.36M0.2%-27.6%8.987%
8/14/2023Rock Springs Capital Management LP1,074,517$3.36M0.1%-76.9%8.999%
8/9/2023TD Asset Management Inc23,497$74K0.0%N/A0.197%
7/13/2023 Key Client Fiduciary Advisors LLC158,597$496K0.3%-89.7%1.328%
5/16/2023Baker BROS. Advisors LP7,425,570$2.53M0.0%+1,226.7%6.218%
5/12/2023Platinum Investment Management Ltd.264,413$90K0.0%-80.1%0.221%
5/11/2023Knott David M Jr557,939$190K0.1%-33.6%0.467%
4/25/2023 Key Client Fiduciary Advisors LLC1,535,816$522K0.3%+13.8%1.293%
2/14/2023683 Capital Management LLC2,750,000$1.24M0.1%+21.4%2.777%
2/13/2023Element Capital Management LLC1,158,551$521K0.3%N/A1.170%
2/13/2023Knott David M Jr840,000$378K0.1%-6.7%0.848%
1/17/2023 Key Client Fiduciary Advisors LLC1,349,321$607K0.4%+20.4%1.363%
11/15/2022Tri Locum Partners LP711,798$626K0.2%N/A0.719%
11/15/2022Perceptive Advisors LLC7,472,148$6.58M0.2%-6.0%7.546%
11/14/2022Annandale Capital LLC40,000$35K0.0%N/A0.040%
11/14/2022683 Capital Management LLC2,265,000$1.99M0.2%+57.3%2.287%
11/7/2022Virtu Financial LLC77,616$68K0.0%+168.9%0.078%
10/12/2022 Key Client Fiduciary Advisors LLC1,120,943$986K0.9%+3.8%1.132%
8/12/2022DLD Asset Management LP500,000$575K0.0%+100.0%0.566%
8/11/2022Knott David M Jr408,953$470K0.2%+1,529.3%0.463%
7/15/2022 Gilman Hill Asset Management LLC22,500$26K0.0%+80.0%0.025%
5/17/2022Rock Springs Capital Management LP3,595,447$6.29M0.2%+2.1%4.071%
5/16/2022J. Goldman & Co LP162,000$284K0.0%-70.0%0.183%
5/16/2022Ghost Tree Capital LLC993,714$1.74M0.4%-26.4%1.125%
5/13/2022DLD Asset Management LP250,000$438K0.0%-63.1%0.283%
5/13/2022M28 Capital Management LP2,664,400$4.66M4.3%+166.4%3.017%
5/12/2022Gyon Technologies Capital Management LP21,659$38K0.0%N/A0.025%
5/11/2022ACT Capital Management LLC265,000$464K0.5%+17.8%0.300%
5/9/2022Qube Research & Technologies Ltd36,246$63K0.0%N/A0.041%
5/2/2022Personal CFO Solutions LLC63,165$111K0.0%-11.2%0.072%
4/29/2022 SG Americas Securities LLC37,877$66K0.0%N/A0.043%
4/25/2022Bailard Inc.34,700$61K0.0%-38.4%0.039%
4/7/2022McAdam LLC48,885$86K0.0%+49.1%0.055%
3/1/2022 Key Client Fiduciary Advisors LLC508,980$1.65M1.4%N/A0.576%
2/16/2022Ghost Tree Capital LLC1,350,000$4.37M1.6%-18.2%1.529%
2/15/2022Coastal Bridge Advisors LLC22,000$71K0.0%N/A0.025%
2/14/2022Ally Bridge Group NY LLC1,815,000$5.88M2.1%+51.3%2.055%
2/11/2022M28 Capital Management LP1,000,000$3.24M2.5%N/A1.132%
2/10/2022Private Advisor Group LLC11,000$36K0.0%N/A0.012%
2/10/2022Bailard Inc.56,300$182K0.0%N/A0.064%
2/9/2022BNP Paribas Arbitrage SA43,947$142K0.0%N/A0.050%
2/8/2022Bank of America Corp DE837,078$2.71M0.0%+14.2%0.948%
2/8/2022Raymond James & Associates35,172$114K0.0%N/A0.040%
2/8/2022ProShare Advisors LLC12,437$40K0.0%N/A0.014%
2/7/2022NorthRock Partners LLC11,915$39K0.0%N/A0.013%
2/3/2022Advisor Group Holdings Inc.50,925$165K0.0%+19.5%0.058%
2/3/2022ACT Capital Management LLC225,000$729K0.5%+45.2%0.255%
2/2/2022Sigma Planning Corp15,500$50K0.0%N/A0.018%
The collapse has already started (Ad)

The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim Plaehn reveals how the 2025 trade war is quietly eroding dividend income — and which U.S.-focused stocks are still raising payouts.

Watch the 2025 Trade War dividend protection briefing now
1/21/2022 Community Trust & Investment Co.13,650$44K0.0%N/A0.015%
1/21/2022 International Assets Investment Management LLC17,500$57K0.0%+75.0%0.020%
1/18/2022 Gilman Hill Asset Management LLC12,500$41K0.0%N/A0.014%
11/18/2021Personal CFO Solutions LLC90,165$362K0.1%+15.4%0.102%
11/16/2021Schonfeld Strategic Advisors LLC35,300$142K0.0%N/A0.059%
11/16/2021ACT Capital L.L.C.155,000$622K0.3%+15.7%0.260%
11/16/2021Opaleye Management Inc.476,000$1.91M0.4%-11.9%0.797%
11/16/2021Squarepoint Ops LLC80,455$323K0.0%N/A0.135%
11/16/2021Tang Capital Management LLC2,500,000$10.03M2.1%N/A4.187%
11/16/2021Two Sigma Advisers LP392,800$1.58M0.0%+19.4%0.658%
(Data available from 1/1/2016 forward)

LPTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LPTX shares?

During the previous two years, 33 institutional investors and hedge funds held shares of Leap Therapeutics. The most heavily invested institutionals were Gilead Sciences Inc. ($15.29M), Point72 Asset Management L.P. ($4.03M), 683 Capital Management LLC ($3.88M), Rock Springs Capital Management LP ($3.36M), Cormorant Asset Management LP ($3.36M), Simplify Asset Management Inc. ($2.72M), and Baker BROS. Advisors LP ($2.53M).Learn more on LPTX's institutional investors.

What percentage of Leap Therapeutics stock is owned by institutional investors?

30.46% of Leap Therapeutics stock is owned by institutional investors. Learn more on LPTX's institutional investor holdings.

Which institutional investors have been buying Leap Therapeutics stock?

Of the 25 institutional investors that purchased Leap Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($6.87M), Gilead Sciences Inc. ($5.32M), Point72 Asset Management L.P. ($1.40M), Simplify Asset Management Inc. ($680.92K), Vanguard Group Inc. ($457.90K), Acuta Capital Partners LLC ($354.17K), and Acadian Asset Management LLC ($219.56K).

How much institutional buying is happening at Leap Therapeutics?

Institutional investors have bought a total of 17,001,086 shares in the last 24 months. This purchase volume represents approximately $50.90M in transactions.

Which Leap Therapeutics major shareholders have been selling company stock?

Of the 13 institutional investors that sold Leap Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($6.14M), Rock Springs Capital Management LP ($3.58M), 683 Capital Management LLC ($2.53M), Key Client Fiduciary Advisors LLC ($1.39M), Platinum Investment Management Ltd. ($1.06M), Cormorant Asset Management LP ($408.47K), and Knott David M Jr ($323.76K).

How much institutional selling is happening at Leap Therapeutics?

Institutional investors have sold a total of 15,963,324 shares in the last 24 months. This volume of shares sold represents approximately $50.19M in transactions.


Related Companies

This page (NASDAQ:LPTX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners
How to invest in Elon Musk’s Optimus before its launch
Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...
InvestorPlace | Sponsored
Is he more powerful than Trump?
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Trump and Buffett Are Quietly Leading America’s Gold Revival
The “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...
Golden Portfolio | Sponsored
James Altucher: Do not invest in AI unless…
I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...
Paradigm Press | Sponsored
The next market Nvidia is positioned to dominate …
Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...
Weiss Ratings | Sponsored
This isn’t a trade war. It’s worse…
Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...
Stansberry Research | Sponsored
They rigged the game
The U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...
Investors Alley | Sponsored
If you missed your chance with Tesla...
Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...
Brownstone Research | Sponsored